Global Top 14 Companies Accounted for 57% of total Mesalamine market (QYResearch, 2021) (Business Opportunities - Marketing & Sales)
AUNetAds > Business Opportunities > Marketing & Sales
Item ID 2400787 in Category: Business Opportunities - Marketing & Sales
Global Top 14 Companies Accounted for 57% of total Mesalamine market (QYResearch, 2021) | |
This report study Mesalamine API market, Mesalamine API is off white to creamish colored powder. Mesalamine also known as Mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective. The global key manufacturers of Mesalamine include Syntese A/S, Divis Laboratories, Ipca Laboratories, Cambrex Corporation, Hangzhou Brother, PharmaZell, Lianyungang Fengheng Biopharm, Lasa Loboratory, Erregierre SpA, Corden Pharma Bergamo, etc. In 2021, the global top five players had a share approximately 57.0% in terms of revenue. For more information, please contact the following e-mail address: Email: global@qyresearch.com Website: https://www.qyresearch.com  | |
| Target State: All States Target City : All Cities Last Update : 25 April 2024 12:01 PM Number of Views: 69 | Item Owner : Frank Contact Email: (None) Contact Phone: (None) |
| Friendly reminder: Click here to read some tips. | |
AUNetAds > Business Opportunities > Marketing & Sales
© 2024 AUNetAds.com
USNetAds.com | GetJob.us | CANetAds.com | UKAdsList.com | INNetAds.com | CNNetAds.com | Hot-Web-Ads.com | USAOnlineClassifieds.com
2024-05-10 (0.222 sec)